aspirin has been researched along with lipoxin b4 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clish, CB; Gronert, K; Petasis, N; Serhan, CN; Takano, T | 2 |
| Chiang, N; Clish, CB; Gronert, K; Levy, BD; Mastalerz, L; Sanak, M; Serhan, CN; Szczeklik, A | 1 |
| Chiang, N; Clish, CB; Gronert, K; Levy, BD; Serhan, CN | 1 |
| Serhan, CN | 1 |
| Ariel, A; Arita, M; Chiang, N; Petasis, NA; Serhan, CN | 1 |
| Parkinson, JF | 1 |
3 review(s) available for aspirin and lipoxin b4
| Article | Year |
|---|---|
Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Inflammation Mediators; Lipoxins; Models, Molecular; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Stereoisomerism | 2000 |
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
Topics: Animals; Arachidonate 5-Lipoxygenase; Aspirin; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Lipoxins; Neutrophils; Receptors, Leukotriene B4; Signal Transduction | 2001 |
Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Humans; Hypersensitivity; Immunity, Cellular; Immunologic Factors; Lipoxins; Mice; Mice, Transgenic; Receptors, Formyl Peptide; Receptors, Lipoxin; T-Lymphocytes | 2006 |
4 other study(ies) available for aspirin and lipoxin b4
| Article | Year |
|---|---|
Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Aspirin; Capillary Permeability; Hydroxyeicosatetraenoic Acids; Lipoxins; Mice; Mice, Inbred BALB C; Mice, Knockout; Molecular Structure; Neutrophils; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Leukotriene B4; Receptors, Lipoxin | 1998 |
Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability.
Topics: Animals; Aspirin; Capillary Permeability; Cell Movement; Fatty Alcohols; Glycols; Hydroxyeicosatetraenoic Acids; Lipoxins; Mice; Mice, Inbred BALB C; Neutrophils; Receptors, Leukotriene B4 | 1999 |
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics.
Topics: Adult; Aspirin; Asthma; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene C4; Lipoxins; Male; Middle Aged; Stereoisomerism | 2000 |
Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butadienes; CD3 Complex; Cell Separation; Enzyme Activation; Humans; Hydroxyeicosatetraenoic Acids; Immune Sera; Immunosuppressive Agents; Jurkat Cells; Leukocytes, Mononuclear; Lipoxins; Lymphocyte Activation; Mitogen-Activated Protein Kinases; Nitriles; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Lipoxin; T-Lymphocytes; Transfection; Tumor Necrosis Factor-alpha | 2003 |